L'Oréal Q126 organic growth beat expectations, FY26 visibility improved but rating maintained at Neutral
AI summary card
L'Oréal Q126 organic growth beat expectations, FY26 visibility improved but rating maintained at Neutral
JPMorgan believes L'Oréal's Q126 LFL growth of +6.7% was better than expected, with broad-based performance across regions and categories, but valuation remains elevated and the mid-term growth gap has narrowed, so it maintains a Neutral rating and €365 target price.
- Q126 underlying LFL growth was +6.7%, above JPMe at +5.1% and consensus at +5.7%; reported LFL was +7.6%.
- Growth was driven by segments such as SAPMENA, North Asia, Professional, and Luxe; the China market recovered to about +2%, with Luxe leading the improvement.
- JPMorgan raised its FY26 LFL forecast from 4.1% to 4.8%, but expects Q2 to slow to 4.4%.
- If oil prices stay at $90-$100, this could create €90-100m of cost pressure; Kering Beauty is expected to have a dilutive impact due to rising inventory.
- The target price is €365 based on a Dec-27 DCF, using WACC of 8.5% and a terminal growth rate of 3.5%.
Report interpretation
Overview
This report is a company research update by JPMorgan on L'Oréal (OREP.PA). The core event is that Q126 sales performance was stronger than expected, with LFL growth spanning multiple regions and business lines, and management remains confident that 2026 will deliver faster growth than 2025. Despite improved short-term earnings quality, the report still emphasizes uncertainty in the global beauty market, normalization of growth in Europe, continued uncertainty in North Asia, and valuation premium risk versus European staples peers.
Core views
JPMorgan maintains a Neutral rating on L'Oréal, believing that the company's medium-term revenue growth of 4-5% does not fully match its current high-premium valuation. In the short term, U.S. demand and improving China trends help ease revenue concerns, while SAPMENA, North Asia, Professional, and Luxe contributed to the broad Q1 beat; however, oil prices, dilution from Kering Beauty, foreign exchange, and cost pressures may offset part of the upside, and there is limited room for consensus upgrades.
Analysis framework
The report mainly analyzes Q126 actual performance versus JPMe and consensus expectations, breaks down LFL growth by region and division, reviews FY26 forecast revisions, DCF target price, and relative valuation, and also uses management call information to assess beauty market momentum, oil-related costs, Kering Beauty impact, and read-through for peer Puig.
Methodology notes
Discounted cash flow target price
The Dec-27 target price of €365 is derived from DCF valuation, with key assumptions including WACC of 8.5% and a terminal growth rate of 3.5%.
Like-for-like/comparable growth breakdown
The report compares Q126 actual LFL, JPMe, and consensus by region and division to determine growth sources and the direction of forecast revisions.
Valuation multiple comparison with European HPC peers
Under the new forecasts, L'Oréal trades at about 25x PE 27E and 15x EV/EBITDA 27E, above European HPC peers at roughly 14x and 10x.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- L'Oréal (OREP.PA)Core covered name
- Strengths
- Q126 LFL beat expectations, with growth across SAPMENA, North Asia, Professional, and Luxe; China improved, U.S. demand provided support, and management is confident in faster growth in 2026.
- Weaknesses
- Medium-term revenue growth is only 4-5%, creating tension with the premium valuation; North Asia and global beauty demand remain uncertain.
- Comparison
- 27E PE is about 25x and EV/EBITDA about 15x, versus roughly 14x and 10x for European HPC peers.
- Risks
- Oil prices and COGS pressure, dilution from Kering Beauty, a stronger euro, worsening trading conditions in Europe/U.S./China, weak travel retail, or M&A impacts.
- PuigPeer read-through name
- Strengths
- The European beauty market is still around 4% and remains resilient.
- Weaknesses
- Fragrance market growth may normalize to the mid-single digits, and the Latin American beauty market is slowing.
- Comparison
- L'Oréal's Q1 performance sends mixed signals for Puig, rather than being a one-way positive.
- Risks
- Latin America slowdown and normalization in the fragrance category may weigh on growth expectations.
Key data
- Q126 underlying LFL growth+6.7%Above JPMe +5.1% and consensus +5.7%.
- Q126 reported LFL growth+7.6%Beat expectations with broad regional coverage.
- FY26 LFL forecast+4.8%JPMorgan raised it from the previous +4.1%.
- Q2 LFL forecast+4.4%The report expects Q2 to slow versus Q1.
- FY26 EPS revision+1%Reflects higher revenue and FX, while also considering Kering dilution and H2 COGS pressure.
- Target price€365.00Dec-27 DCF target price.
- Current price€344.90As of 2026-04-22.
- Valuation multiples25x PE 27E；15x EV/EBITDA 27EStill above European HPC peers.
- Potential oil price impact€90-100mIf oil prices remain at $90-$100, the unhedged impact would be about 20bps on FY margin.
- FY26 revenue forecast€46,118mJPMorgan forecast, close to consensus at €46,111m.
- FY26 adjusted EPS forecast€13.25JPMorgan forecast, below BBG EPS of €13.55.
Impact & implications
The market may react positively in the short term to the strong and broad-based Q126 beat, especially after recent share price weakness; however, since JPMorgan expects only limited consensus upgrades and the company still trades in a high-valuation range, absolute upside may be constrained. The read-through for peer Puig is more mixed: fragrance market growth may normalize to the mid-single digits, Latin American beauty is slowing, but the European beauty market remains resilient.
Risks
- A weaker-than-expected recovery in China, resulting in insufficient improvement in Luxe and Travel Retail.
- Deteriorating trading conditions in key markets such as Europe, the U.S., or China.
- Oil prices remaining elevated and pushing up logistics and raw material procurement costs.
- Rising Kering Beauty inventory creating dilution impact in the tens of millions of euros.
- A stronger euro could lead to earnings downgrades.
- Retail slowdown or travel restrictions could weigh on demand.
- Changes in minority interest value or M&A events could affect valuation.
What to watch
- Whether FY26 LFL growth can reach JPMorgan's raised forecast of 4.8%.
- Whether Q2 slows to around 4.4% LFL as the report expects.
- Whether the China market continues to recover, especially in Luxe and Travel Retail.
- Whether sell-out in North American CPD continues to outperform sell-in.
- Whether high-growth markets in SAPMENA such as India and Vietnam can offset weakness in the UAE.
- The actual impact of oil prices and H2 COGS on gross margin and EBIT margin.
- The degree of dilution from Kering Beauty consolidation or rising inventory.
- Whether consensus forecasts are revised upward and whether the share price reaction breaks through valuation constraints.